scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1068965792 |
P356 | DOI | 10.2119/MOLMED.2015.00193 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.2119/molmed.2015.00193 |
P932 | PMC publication ID | 4818268 |
P698 | PubMed publication ID | 26701314 |
P50 | author | Gabriella Leung | Q42099320 |
P2093 | author name string | Derek M McKay | |
Jordan Iannuzzi | |||
Arthur Wang | |||
Björn Petri | |||
José Luis Reyes | |||
P2860 | cites work | PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells | Q24677367 |
Macrophage heterogeneity in tissues: phenotypic diversity and functions | Q26861223 | ||
Adoptive immunotherapy for cancer: harnessing the T cell response | Q28262548 | ||
The M1 and M2 paradigm of macrophage activation: time for reassessment | Q29615845 | ||
Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis | Q33429032 | ||
A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells | Q33778379 | ||
Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis | Q34202877 | ||
Dendritic-cell-based therapeutic cancer vaccines | Q34360094 | ||
Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo | Q34372109 | ||
Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium | Q34643625 | ||
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. | Q34718815 | ||
Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis? | Q34779125 | ||
Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function | Q35884586 | ||
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation | Q36231523 | ||
Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice | Q36339559 | ||
Advances in stem cell therapy for spinal cord injury | Q36357908 | ||
IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages | Q36501243 | ||
Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity | Q36946566 | ||
Stem cell therapy in inflammatory bowel disease: which, when and how? | Q38105943 | ||
Stem cells as potential targeted therapy for inflammatory bowel disease | Q38191335 | ||
Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis | Q38623517 | ||
Integrin alpha E(CD103)beta 7 mediates adhesion to intestinal microvascular endothelial cell lines via an E-cadherin-independent interaction | Q40826621 | ||
Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts | Q40852538 | ||
Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages. | Q41632235 | ||
Regulation of obesity-related insulin resistance with gut anti-inflammatory agents | Q42174194 | ||
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease | Q42663033 | ||
Liposomes for specific depletion of macrophages from organs and tissues | Q43194945 | ||
In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice | Q43203596 | ||
Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation | Q44086481 | ||
Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells | Q44217456 | ||
Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10. | Q44583364 | ||
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. | Q50437860 | ||
SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis. | Q52612704 | ||
The therapeutic helminth? | Q55051382 | ||
Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant Recipients | Q56989328 | ||
Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis | Q58862703 | ||
Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease | Q59391845 | ||
Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells | Q73082037 | ||
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages | Q84396444 | ||
Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2 | Q84563119 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cryopreservation | Q1144664 |
P304 | page(s) | 924-936 | |
P577 | publication date | 2015-12-09 | |
P1433 | published in | Molecular Medicine | Q6895961 |
P1476 | title | Cryopreserved Interleukin-4-Treated Macrophages Attenuate Murine Colitis in an Integrin β7 - Dependent Manner | |
P478 | volume | 21 |
Q90313359 | Alternatively activated macrophages promote resolution of necrosis following acute liver injury |
Q53422544 | Discovering Macrophage Functions Using In Vivo Optical Imaging Techniques. |
Q39440518 | Helminth Regulation of Immunity: A Three-pronged Approach to Treat Colitis |
Q90699508 | Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium |
Q37589645 | Suppression of colitis by adoptive transfer of helminth antigen-treated dendritic cells requires interleukin-4 receptor-α signaling |
Search more.